Aceclidine
Aceclidine (Glaucostat, Glaunorm, Glaudin) is a parasympathomimetic miotic agent used in the treatment of narrow angle glaucoma. It decreases intraocular pressure.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical (ophthalmic solution) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | deacetylation? |
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.011.431 |
Chemical and physical data | |
Formula | C9H15NO2 |
Molar mass | 169.224 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Adverse effects
Side effects of aceclidine include increased salivation and bradycardia (in excessive doses).
Mechanism of action
Aceclidine acts as a muscarinic acetylcholine receptor agonist.[1]
See also
- Talsaclidine (drug with a similar structure)
- Muscarine
References
- Shannon HE, Hart JC, Bymaster FP, et al. (August 1999). "Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats". J. Pharmacol. Exp. Ther. 290 (2): 901–7. PMID 10411607.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.